Fig. 3
From: Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
Cost-effectiveness acceptability curve for PAH patients in FC III receiving sildenafil and beraprost
Fig. 3 | BMC Health Services Research
